Vet oncology to be worth nearly $580 million

The market for veterinary oncology is expected to attain a value of $578.0 million by the year 2030, according to a report by the market analysts, Grand View Research, Inc. The global market is projected to grow at a CAGR of 12.1% across the forecast period of 2022 to 2030. 

An uptick in the market is based on increasing rates of cancer in companion animals and pet owners’ interest in cancer diagnostics. Additionally, the high number of advancements and technology and therapeutics being studied are expected to feed the growth of the global market during the forecast period. 

When looking at the different segments across the markets, the chemotherapy segment held the largest share of revenue in the forecast period. The treatment is the most common for cancer whether it is used as a single or combination regimen. By type of cancer, lymphoma was prevalent in the market in 2021 likely because the disease is most likely to lead to death and thereby potentially lead to aggressive treatment methods. 

If evaluating the market by type of companion animals receiving oncology therapy, dogs were in the top revenue spot in 2021 as the rates of cancer are higher in dogs and more dogs have been adopted in recent years. By geography, North America took the top spot with the greatest share in 2021 based on the number of new products, spending on veterinary oncology, and government that is favorable to therapies. 

  • Please enter a comment

Name *
Email address *
Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

More news

Sploot opens second clinic in Denver, with more on the way


Dr. Christopher Byers: The pandemic broke me


Disaster preparedness for animals


Echocardiographic indicators of fluid responsiveness in hospitalized dogs with compromised hemodynamics, tissue hypoperfusion


Morris Animal Foundation accepting RFPs to use golden retriever study data, samples




News of interest


Copyright © 2022 - All Rights Reserved
ISSN 2768-198X